Detection of the levels of neuropeptides, ACTH and cortisol in the blood of patients with polymyositis/dermatomyositis and their significance

Journal of Dermatology

Volumn 31, Issue 5, 2004, Pages 392-397

  Liu, Jifeng ^a,b   Li, Jiuhong ^a   Zhai, Ning ^a   Geng, Long ^a   Song, Fangji ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Third Hospital of Hangzhou   (China)

Author keywords

Adrenocoricotropic hormone; Beta endorphin; Calcitonin gene related peptide; Neuropeptide Y; Polymyositis dermatomyositis

Indexed keywords

BETA ENDORPHIN; CALCITONIN GENE RELATED PEPTIDE; CORTICOTROPIN; HYDROCORTISONE; NEUROPEPTIDE; NEUROPEPTIDE Y;

ADULT; AGE; AGED; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DERMATOMYOSITIS; DISEASE DURATION; FEMALE; HOMEOSTASIS; HORMONAL REGULATION; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMMUNE SYSTEM; MALE; PATHOGENESIS; POLYMYOSITIS; RADIOIMMUNOASSAY; BLOOD; CASE CONTROL STUDY; MIDDLE AGED;

ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; BETA-ENDORPHIN; CALCITONIN GENE-RELATED PEPTIDE; CASE-CONTROL STUDIES; DERMATOMYOSITIS; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; NEUROPEPTIDE Y; RADIOIMMUNOASSAY;

EID: 3042585051     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2004.tb00690.x     Document Type: Article

References (25)

1. Engel AG, Arahata K, Emslie-Smith A: Immune effector mechanisms in inflammatory myopathies, Res Publ Assoc Res Nerv Ment Dis, 68: 141-157, 1990.
2. Sterzl I: Neuroendocrine-immune system: Interaction and regulation, Folia Biol Praha, 42: 67-71, 1996.
3. Blalock JE: A molecular basis for bi-directional communication between the immune and neuroendocrine system, J Physiol, 69: 1-32, 1989.
4. Hermus AR, Sweep CG: Cytokines and the hypothalamic-pituitary-adrenal axis, J Steroid Biochem Mol Biol, 37: 867-871, 1990.
5. Liu G, Chen YT, Huang MH: The change of neuropeptide Y in plasma of SLE patients, J Immunol, 17: 398, 2001.
6. Larsson J, Ekblom A, Henriksson K, Lundeberg T, Theodorsson E: Concentration of substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis, Scand J Rheumatol, 20: 326-335, 1991.
7. Gironi M, Furlan R, Rovaris M, et al: Beta endorphin concentrations in PBMC of patients with different clinical phenotypes of multiple sclerosis, J Neurol Neurosurg Psychiatry, 74: 495-497, 2003.
8. Bohan A, Peter JB: Polymyositis and dermatomyositis, N Engl J Med, 292: 403-407, 1975.
9. Liu JH, Gao KB, Liu JF, et al: Detection and the significance of neuropeptide levels in plasma of SLE patients, Chin J Dermatol, 36: 49, 2003.
10. Mazzocchi G, Malendowicz LK, Macchi C, Gottardo G, Nussdorfer GG: Further investigations on the effects of neuropeptide Y on the secretion and growth of rat adrenal zona glomerulosa, Neuropeptides, 30: 19-27, 1996.
11. Khachatryan A, Guerder S, Palluault F, et al: Targeted expression of the neuropeptide calcitonin gene-related peptide to beta cells prevents diabetes in NOD mice, J Immunol, 158:1409-1416, 1997.
12. Sakuta H, Inaba K, Muramatsu S: Calcitonin gene-related peptide enhances apoptosis of thymocytes, J Neuroimmunol, 67: 103-109, 1996.
13. Tao Y: The change of CGRP and ET-1 in serum during activity of SLE, Chin J Rheumatol, 2: 161-163, 1997.
14. Tews DS, Goebel HH: Cytokine expression profile in idiopathic inflammatory myopathies, J Neuropathol Exp Neurol, 55: 342-347, 1996.
15. Lepidi H, Frances V, Figarella-Branger D, Bartoli C, Machado-Baeta A, Pellissier JF: Local expression of cytokines in idiopathic inflammatory myopathies, Neuropathol Appl Neurobiol, 24: 73-79, 1998.
16. Elbeialy A, Elbarbary M, Kamel M: Peripheral beta-endorphin in rheumatoid arthritis. A correlation with the disease activity, Scand J Rheumatol, 26: 88-91, 1997.
17. Mukai E, Nagashima M, Hirano D, Yoshino S: Comparative study of symptoms and neuroendocrine-immune network mediator levels between rheumatoid arthritis patients and healthy subjects, Clin Exp Rheumatol, 18: 585-590, 2000.
18. Wiedermann CJ, Sacerdote P, Propst A, et al: Decreased beta-endorphin content in peripheral blood mononuclear leukocytes from patients with Crohn's disease, Brain Behav Immun, 8: 261-269, 1994.
19. Mansour A, Fox CA, Akil H, Watson SJ: Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications, Trends Neurosci, 18: 22-29, 1995.
20. Morch H, Pedersen BK: Beta-endorphin and the immune system - Possible role in autoimmune diseases, Autoimmunity, 21: 161-171, 1995.
21. Gonzalez-Amaro R, Alcocer-Varela J, Alarcon-Segovia D: Natural killer cell activity in dermatomyositis-polymyositis, J Rheumatol, 14: 307-310, 1987.
22. Chen XF, Yu YM, Shen JL, Liu ZM, Zhang RZ: The study on the change of glucocorticoid receptorin peripheral leukocytes from patients with polymyositis/dermatomyositis, Shanghai J Immunol, 21: 276-278, 2001.
23. Zhang WY: Neuroendocrinology foreword, in Jin BQ (ed): Cell and Molecular Immunology, World Book Publications, Shanghai, 1998, pp 335-372.
24. Chen HL, Chen WQ Hu F, Cai YQ: ACTH test on child patients with nephropathy syndrome treated by hormone in order to determine function of adrenocortical, Acta Academiae Medicinae Hubai, 18: 82-84, 1997.
25. Shi SY, Qiao XY: Dermatomyositis, in Jiang M, Zhu LP, Lin XY (eds): Rheumatology, Beijing Science Publications, Beijing, 1995, pp 1083-1103.